The synchronization of diabetes data on the mobile, which will optimize therapeutic information, protagonist at the Attd Congress, which has been held in Vienna.
With the aim of publicizing the avant -garde projects in the Diabetes field, the Congress of Technological and Treatment Advances in Diabetes (ATTD) has been organized in Vienna (Austria), to which industry, health professionals and patients have attended.
The main novelty that has been observed in companies' strategies is the interest in offering packages with integrated products that include both an insulin pump and a mobile application that allows the patient to follow up on their own diabetes case.
To achieve this, several companies are developing a system that is composed of three steps: the first is the sensor that, located in the patient's body, extracts the relevant data for treatment and is known as continuous glucose monitor (CGM, by itsacronym in English);The second is the control algorithm that, although it has normally been part of the devices attached to the insulin pump, is currently being incorporated into formats compatible with smartphones;and finally, the insulin supplier in the form of a pump or pen.
new ‘wearables'
"At present, a new generation of wearables has emerged as smart bracelets that connect to the smartphone and offer health data continuously to the user. This technology can be applied to people with diabetes and help them in their day to day forReducing glycemic attacks, "explained Eyal Dassau, senior biomedical engineering researcher at the John A. Paulson School of Applied Sciences of the University of Hardvard (United States).
As he explains, in the future "to be able to create an application that can estimate the impact of certain meals on the patient's glycemic index with just taking a photo and prediction algorithm that takes into account the influence of unexpected meals."
The new integrated diabetes treatments will have as a direct consequence the creation of large amounts of health data that, for the moment, will be in charge of the supply companies: "Today, pharmacists are collaborating with software creative companies.This is the case of Lilly Laboratories and the Livongo company.
The manufacture of these products is a complicated task since it must guarantee the privacy of the data and, at the same time, conserve the simplicity that allows them to be easy to handle, "said David Klonoff, founder of the cybersecurity program in technology for technologyDiabetes on connected devices (DTSEC).
‘app 'for day to day
The celebration of the Congress Technological and Treatment Advances in Diabetes in Vienna has allowed the international community to be known to a local start-up that has developed an application for smartphone known as MySugg.
The app can be connected to several devices and interpret data and is designed for people with diabetes to delegate to it a part of the monitoring of their therapy: "It has been demonstrated through a study that people with diabetes who used the application of MySuggFor four weeks they saw their glycemic levels reduced as well as the risk of hypoglycemia, "explained Anton Kittelberger, co-founder of MySugr.This tool has a coaching section in which specialized professionals offer advice and has become part of the integrated solutions offered by Roche Diabetes Healthcare.
compromise the patient
An American project known as Canary Health that focuses on theEmpowerment of people with a chronic disease through coaching, says Neal Kaufman, head of Medicine of Canary Health.
As he explains, "therapies, devices and numbers are not enough in the approach to diabetes. When the patient has more information and can have decisions he feels more committed to his own state of health. This attitude helps them in managementof their emotions and their relationships, which has an impact on a reduction in the risk of depression. "